TELA Bio, Inc. Accounts Receivable, Allowance for Credit Loss, Writeoff
TELA Bio, Inc. (TELA) reported Accounts Receivable, Allowance for Credit Loss, Writeoff of $85.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Notes
us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs · last filed 2026-03-25
- TELA Bio, Inc. accounts receivable, allowance for credit loss, writeoff for fiscal 2025 was $85.00K, a 58.74% decline from fiscal 2024.
- TELA Bio, Inc. accounts receivable, allowance for credit loss, writeoff for fiscal 2024 was $206.00K, a 524.24% increase from fiscal 2023.
- TELA Bio, Inc. accounts receivable, allowance for credit loss, writeoff for fiscal 2023 was $33.00K, a 32.00% increase from fiscal 2022.
- TELA Bio, Inc. accounts receivable, allowance for credit loss, writeoff for fiscal 2022 was $25.00K, a 316.67% increase from fiscal 2021.
| Period end | Accounts Receivable, Allowance for Credit Loss, Writeoff 12 month |
|---|---|
| 2025-12-31 | $85.00K 10-K · filed 2026-03-25 |
| 2024-12-31 | $206.00K 10-K · filed 2026-03-25 |
| 2023-12-31 | $33.00K 10-K · filed 2026-03-25 |
| 2022-12-31 | $25.00K 10-K · filed 2025-03-21 |
| 2021-12-31 | $6.00K 10-K · filed 2024-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |